文献速递慢性肾脏病血液净化与透析

预测晚期慢性肾脏病患者的肾衰竭、心血管疾病与死亡

Predicting Kidney Failure, Cardiovascular Disease and Death in Advanced CKD Patients.
PubMed 文献 · Kidney Int Rep · 2022-08-02

本研究在欧洲多中心前瞻性队列(EQUAL研究)中纳入1517例≥65岁肾内科转诊的晚期慢性肾脏病患者,外部验证新开发的CKD G4+风险计算器对肾脏替代治疗、心血管事件和死亡的预测性能。模型对肾脏替代治疗和「肾脏替代治疗后死亡」的区分度良好(2年C统计量分别为0.74和0.76),对心血管事件(0.70)和总体死亡(0.61)的区分度较差,校准度尚可。决策曲线分析显示,使用该模型指导血管通路转诊通常比依据估算肾小球滤过率阈值减少未使用的动静脉内瘘。

要点

  • 模型对肾脏替代治疗和「肾脏替代治疗后死亡」的2年C统计量分别为0.74和0.76,区分度良好。
  • 模型对心血管事件(2年C统计量0.70)和总体死亡(0.61)的区分度较差。
  • 决策曲线分析显示,用模型指导血管通路转诊通常比依据估算肾小球滤过率阈值减少未使用的动静脉内瘘。

核心结论

  • 该模型在≥65岁肾内科转诊的晚期慢性肾脏病患者队列中显示出中等至良好的预测性能。
  • 使用该模型指导血管通路转诊在减少不必要的血管手术方面具有潜力。

研究设计与样本

  • 研究为外部验证,数据来自欧洲多中心前瞻性队列研究EQUAL,纳入1517例≥65岁肾内科转诊的晚期慢性肾脏病患者。
  • 模型性能基于区分度和校准度评估,并采用诊断指标和决策曲线分析研究其在血管通路转诊时机方面的潜在临床效用。

主要发现

  • 模型对肾脏替代治疗和「肾脏替代治疗后死亡」的2年C统计量分别为0.74和0.76。
  • 模型对心血管事件的2年C统计量为0.70,对总体死亡的2年C统计量为0.61。
  • 校准度尚可。
  • 决策曲线显示,使用模型指导血管通路转诊通常比依据估算肾小球滤过率阈值减少未使用的动静脉内瘘。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Predicting the timing and occurrence of kidney replacement therapy (KRT), cardiovascular events, and death among patients with advanced chronic kidney disease (CKD) is clinically useful and relevant. We aimed to externally validate a recently developed CKD G4+ risk calculator for these outcomes and to assess its potential clinical impact in guiding vascular access placement. METHODS: We included 1517 patients from the European Quality (EQUAL) study, a European multicentre prospective cohort study of nephrology-referred advanced CKD patients aged ≥65 years. Model performance was assessed based on discrimination and calibration. Potential clinical utility for timing of referral for vascular access placement was studied with diagnostic measures and decision curve analysis (DCA). RESULTS: The model showed a good discrimination for KRT and "death after KRT," with 2-year concordance (C) statistics of 0.74 and 0.76, respectively. Discrimination for cardiovascular events (2-year C-statistic: 0.70) and overall death (2-year C-statistic: 0.61) was poorer. Calibration was fairly accurate. Decision curves illustrated that using the model to guide vascular access referral would generally lead to less unused arteriovenous fistulas (AVFs) than following estimated glomerular filtration rate (eGFR) thresholds. CONCLUSION: This study shows moderate to good predictive performance of the model in an older cohort of nephrology-referred patients with advanced CKD. Using the model to guide referral for vascular access placement has potential in combating unnecessary vascular surgeries.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Ramspek CL, Boekee R, Evans M, et al. Predicting Kidney Failure, Cardiovascular Disease and Death in Advanced CKD Patients. Kidney Int Rep. 2022. PMID: 36217520. doi:10.1016/j.ekir.2022.07.165

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。